Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Novavax has acquired two manufacturing and office facilities through a long-term lease arrangement in Gaithersburg, MD, US.
Subscribe to our email newsletter
The main facility will be used for commercial-scale production of the company’s vaccines and is said to provide twice the cGMP production capacity of their current facility.
Novavax president and CEO Stanley C Erck said the new plant would help them supply vaccines including seasonal and pandemic VLP influenza vaccines.
"In addition to cGMP facilities, these buildings will accommodate current and future clinical, R&D and administrative requirements," Erck added.